* NextGen Healthcare Inc NXGN.OQ NXGN.O is expected
to show a
rise in quarterly revenue when it reports results on October
25.
* The Atlanta Georgia-based company is expected to report
a
4.8% increase in revenue to $156.485 million from $149.29
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for NextGen Healthcare
Inc is
for earnings of 23 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for NextGen
Healthcare Inc is $20, above its last closing price of $18.53.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 0.16 0.16 0.16 Met 2.6
Mar. 31 2022 0.19 0.19 0.19 Met -2.2
Dec. 31 2021 0.20 0.21 0.24 Beat 15.2
Sep. 30 2021 0.24 0.23 0.29 Beat 26.1
Jun. 0.21 0.21 0.25 Beat 20.3
30 2021
Mar. 31 2021 0.19 0.19 0.21 Beat 8.8
Dec. 31 2020 0.24 0.25 0.26 Beat 5.4
Sep. 30 2020 0.20 0.20 0.30 Beat 48.5
This summary was machine generated October 22 at 01:21 GMT. All
figures in US dollars unless otherwise stated